What is MapLight Therapeutics, Inc. 's other non-current assets?

MapLight Therapeutics, Inc. (MPLT) reported other non-current assets of $36K in Q1 2026.

What does other non-current assets mean?

Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

MapLight Therapeutics, Inc. MPLT Other Non-Current Assets

Other Non-Current Assets at other companies

Neurocrine BiosciencesNBIX

$20.1M-8.6%

Acadia PharmaceuticalsACAD

$3.93M+170%

MeiraGTx Holdings plcMGTX

$1.47M+42.1%

Alto NeuroscienceANRO

$338K-40.6%

Zevra Therapeutics, Inc.ZVRA

$143K-51.2%

Rapport Therapeutics, Inc.RAPP

$1.06M+401%

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's other non-current assets?: MapLight Therapeutics, Inc. (MPLT) reported other non-current assets of $36K in Q1 2026.
What does other non-current assets mean?: Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.